121 related articles for article (PubMed ID: 11171577)
1. Redistribution and abnormal activity of phospholipase A(2) isoenzymes in postinfarct congestive heart failure.
McHowat J; Tappia PS; Liu S; McCrory R; Panagia V
Am J Physiol Cell Physiol; 2001 Mar; 280(3):C573-80. PubMed ID: 11171577
[TBL] [Abstract][Full Text] [Related]
2. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril.
Tappia PS; Liu SY; Shatadal S; Takeda N; Dhalla NS; Panagia V
Am J Physiol; 1999 Jul; 277(1):H40-9. PubMed ID: 10409180
[TBL] [Abstract][Full Text] [Related]
3. Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure.
Yu CH; Panagia V; Tappia PS; Liu SY; Takeda N; Dhalla NS
Biochim Biophys Acta; 2002 Sep; 1584(1):65-72. PubMed ID: 12213494
[TBL] [Abstract][Full Text] [Related]
4. Depressed responsiveness of phospholipase C isoenzymes to phosphatidic acid in congestive heart failure.
Tappia PS; Yu CH; Di Nardo P; Pasricha AK; Dhalla NS; Panagia V
J Mol Cell Cardiol; 2001 Mar; 33(3):431-40. PubMed ID: 11181012
[TBL] [Abstract][Full Text] [Related]
5. Expression of phospholipase D isozymes in scar and viable tissue in congestive heart failure due to myocardial infarction.
Dent MR; Singal T; Dhalla NS; Tappia PS
J Cell Mol Med; 2004; 8(4):526-36. PubMed ID: 15601581
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction.
Sethi R; Dhalla KS; Ganguly PK; Ferrari R; Dhalla NS
Cardiovasc Res; 1999 Jun; 42(3):607-15. PubMed ID: 10533600
[TBL] [Abstract][Full Text] [Related]
7. Identification of changes in cardiac phospholipase C activity in congestive heart failure.
Meij JT; Panagia V; Mesaeli N; Peachell JL; Afzal N; Dhalla NS
J Mol Cell Cardiol; 1997 Jan; 29(1):237-46. PubMed ID: 9040038
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase A2-mediated activation of phospholipase D in rat heart sarcolemma.
Liu SY; Tappia PS; Dai J; Williams SA; Panagia V
J Mol Cell Cardiol; 1998 Jun; 30(6):1203-14. PubMed ID: 9689594
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in sarcolemmal phospholipase D and phospholipase C isoenzymes and in their interactions in post-infarcted failing hearts.
Panagia V; Tappia PS; Yu C; Takeda N; Dhalla NS
Lipids; 1999; 34 Suppl():S73-4. PubMed ID: 10419094
[No Abstract] [Full Text] [Related]
10. Depressed phosphatidic acid-induced contractile activity of failing cardiomyocytes.
Tappia PS; Maddaford TG; Hurtado C; Panagia V; Pierce GN
Biochem Biophys Res Commun; 2003 Jan; 300(2):457-63. PubMed ID: 12504106
[TBL] [Abstract][Full Text] [Related]
11. Roles of phospholipase A2 isoforms in swelling- and melittin-induced arachidonic acid release and taurine efflux in NIH3T3 fibroblasts.
Pedersen SF; Poulsen KA; Lambert IH
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1286-96. PubMed ID: 16855215
[TBL] [Abstract][Full Text] [Related]
12. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
[TBL] [Abstract][Full Text] [Related]
13. Low level of sarcolemmal phosphatidylinositol 4,5-bisphosphate in cardiomyopathic hamster (UM-X7.1) heart.
Ziegelhoffer A; Tappia PS; Mesaeli N; Sahi N; Dhalla NS; Panagia V
Cardiovasc Res; 2001 Jan; 49(1):118-26. PubMed ID: 11121803
[TBL] [Abstract][Full Text] [Related]
14. Identification of the phospholipase A(2) isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A(2) inhibitors.
Michiels C; Renard P; Bouaziz N; Heck N; Eliaers F; Ninane N; Quarck R; Holvoet P; Raes M
Biochem Pharmacol; 2002 Jan; 63(2):321-32. PubMed ID: 11841807
[TBL] [Abstract][Full Text] [Related]
15. Induction of Ca-independent PLA(2) and conservation of plasmalogen polyunsaturated fatty acids in diabetic heart.
McHowat J; Creer MH; Hicks KK; Jones JH; McCrory R; Kennedy RH
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E25-32. PubMed ID: 10893319
[TBL] [Abstract][Full Text] [Related]
16. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
17. Phospolipase A2 and apoptosis.
Taketo MM; Sonoshita M
Biochim Biophys Acta; 2002 Dec; 1585(2-3):72-6. PubMed ID: 12531539
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 expression in tumours: a target for therapeutic intervention?
Laye JP; Gill JH
Drug Discov Today; 2003 Aug; 8(15):710-6. PubMed ID: 12927514
[TBL] [Abstract][Full Text] [Related]
19. Clinical concentrations of doxorubicin inhibit activity of myocardial membrane-associated, calcium-independent phospholipase A(2).
McHowat J; Swift LM; Arutunyan A; Sarvazyan N
Cancer Res; 2001 May; 61(10):4024-9. PubMed ID: 11358821
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cytosolic phospholipase A(2), calcium independent phospholipase A(2) and plasmalogen selective phospholipase A(2) in neurodegenerative and neuropsychiatric conditions.
Ong WY; Farooqui T; Farooqui AA
Curr Med Chem; 2010; 17(25):2746-63. PubMed ID: 20586719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
